Accrued Expenses (Tables)

3 Months Ended

Mar. 31, 2026

Accrued Expenses [Abstract]

Accrued Expenses

Accrued expenses included the following:

		March 31,	December 31,
		2026	2025
Incentive and other compensation costs	$	753,161	870,910
Clinical trial costs		170,459	259,293
Director fees		71,250	71,250
Other		29,836	64,320
Accrued expenses	$	1,024,706	1,265,773